Raynaud's phenomenon induced by drugs acting on neurotransmission: two cases under reboxetine and one under tegaserod

Eur J Clin Pharmacol. 2003 Feb;58(10):717. doi: 10.1007/s00228-002-0552-4. Epub 2003 Jan 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adrenergic Uptake Inhibitors / adverse effects*
  • Adrenergic Uptake Inhibitors / therapeutic use
  • Adult
  • Female
  • Humans
  • Indoles / adverse effects*
  • Indoles / therapeutic use
  • Morpholines / adverse effects*
  • Morpholines / therapeutic use
  • Raynaud Disease / chemically induced*
  • Reboxetine
  • Serotonin Receptor Agonists / adverse effects*
  • Serotonin Receptor Agonists / therapeutic use

Substances

  • Adrenergic Uptake Inhibitors
  • Indoles
  • Morpholines
  • Serotonin Receptor Agonists
  • tegaserod
  • Reboxetine